Early Health Technology Assessment

The assessment of a health technology during development to inform design, evidence generation, pricing and market-access strategy.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.

Early health technology assessment takes place during a health technology's development, before it is finished, so that its findings can inform design, evidence generation, pricing and market-access strategy. Assessing at this early stage lets the results shape the technology while choices remain open. This timing during development is what makes the assessment early By bringing evaluation forward into development, the approach lets evidence, design and pricing decisions be steered while they can still be changed, rather than judged only once the technology is finished.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.

Early health technology assessment informs design, evidence generation, pricing and market-access strategy, feeding into decisions about how the technology is developed and brought to market. By providing analysis during development, it guides these choices while they can still be changed. Informing design, evidence generation, pricing and market access is the purpose of early health technology assessment By bringing evaluation forward into development, the approach lets evidence, design and pricing decisions be steered while they can still be changed, rather than judged only once the technology is finished.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.

Early health technology assessment examines a health technology during its development, assessing it to inform design, evidence generation, pricing and market-access strategy. The technology under development is the object of the assessment. Examining a health technology at the development stage is central to what early health technology assessment does By bringing evaluation forward into development, the approach lets evidence, design and pricing decisions be steered while they can still be changed, rather than judged only once the technology is finished.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.

Early health technology assessment is carried out during development so its findings can shape the technology while design, evidence generation, pricing and market-access strategy are still being decided. Assessing early means the analysis can influence choices before they are fixed. This purpose of informing decisions while they remain open is why the assessment is done during development By bringing evaluation forward into development, the approach lets evidence, design and pricing decisions be steered while they can still be changed, rather than judged only once the technology is finished.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.

Early health technology assessment assesses a health technology during development to inform design, evidence generation, pricing and market-access strategy, while health technology assessment more broadly evaluates the value of a health technology to inform decisions about its use. Early assessment applies the same evaluative thinking at the development stage rather than at adoption. The two are connected as assessment of a technology at earlier and later points in its life By bringing evaluation forward into development, the approach lets evidence, design and pricing decisions be steered while they can still be changed, rather than judged only once the technology is finished.

Source: IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied Health Economics and Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000.